| extracellular matrix organization | GO:0030198 | 147 | 0.739 | |
| protein hydroxylation | GO:0018126 | 4 | 0.619 | |
| extracellular structure organization | GO:0043062 | 148 | 0.513 | |
| collagen fibril organization | GO:0030199 | 32 | 0.463 | |
| wound healing | GO:0042060 | 157 | 0.153 | |
| skeletal system development | GO:0001501 | 356 | 0.152 | |
| connective tissue development | GO:0061448 | 179 | 0.113 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.101 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.085 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.083 | |
| oxidation reduction process | GO:0055114 | 342 | 0.081 | |
| fibrinolysis | GO:0042730 | 3 | 0.077 | |
| membrane raft assembly | GO:0001765 | 3 | 0.077 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.074 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.070 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.067 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.065 | |
| ossification | GO:0001503 | 216 | 0.064 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.064 | |
| cartilage development | GO:0051216 | 140 | 0.060 | |
| chromatin organization | GO:0006325 | 206 | 0.058 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.055 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.053 | |
| peptidyl proline hydroxylation | GO:0019511 | 3 | 0.052 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.051 | |
| angiogenesis | GO:0001525 | 201 | 0.050 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.049 | |
| immune effector process | GO:0002252 | 321 | 0.049 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.048 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.046 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.046 | |
| collagen biosynthetic process | GO:0032964 | 7 | 0.046 | |
| anion transport | GO:0006820 | 177 | 0.046 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.044 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.044 | |
| regulation of integrin mediated signaling pathway | GO:2001044 | 8 | 0.044 | |
| head morphogenesis | GO:0060323 | 34 | 0.043 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.042 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.042 | |
| fat cell differentiation | GO:0045444 | 160 | 0.040 | |
| endomembrane system organization | GO:0010256 | 147 | 0.040 | |
| bone development | GO:0060348 | 120 | 0.039 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.039 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.039 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.039 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.038 | |
| response to acid chemical | GO:0001101 | 111 | 0.038 | |
| synaptic transmission | GO:0007268 | 329 | 0.037 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.037 | |
| spermatogenesis | GO:0007283 | 284 | 0.037 | |
| cation transport | GO:0006812 | 399 | 0.037 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.037 | |
| regulation of cell motility | GO:2000145 | 236 | 0.036 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.036 | |
| protein maturation | GO:0051604 | 176 | 0.034 | |
| synaptic transmission cholinergic | GO:0007271 | 7 | 0.034 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.034 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.034 | |
| peptidyl proline modification | GO:0018208 | 6 | 0.033 | |
| cerebral cortex development | GO:0021987 | 86 | 0.033 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.032 | |
| lung development | GO:0030324 | 164 | 0.032 | |
| organic acid transport | GO:0015849 | 101 | 0.032 | |
| male gamete generation | GO:0048232 | 285 | 0.032 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.031 | |
| cell adhesion | GO:0007155 | 329 | 0.030 | |
| digestive tract development | GO:0048565 | 190 | 0.030 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.029 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.028 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.028 | |
| localization within membrane | GO:0051668 | 4 | 0.027 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.027 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.027 | |
| response to hypoxia | GO:0001666 | 58 | 0.026 | |
| positive regulation of interleukin 6 secretion | GO:2000778 | 1 | 0.026 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.026 | |
| respiratory tube development | GO:0030323 | 167 | 0.026 | |
| tissue homeostasis | GO:0001894 | 115 | 0.026 | |
| fibril organization | GO:0097435 | 2 | 0.026 | |
| sphingolipid biosynthetic process | GO:0030148 | 26 | 0.026 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.025 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.025 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.025 | |
| defense response to other organism | GO:0098542 | 197 | 0.024 | |
| chondrocyte development | GO:0002063 | 24 | 0.024 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.024 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.024 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.024 | |
| stem cell development | GO:0048864 | 219 | 0.024 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.023 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.023 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.023 | |
| replacement ossification | GO:0036075 | 26 | 0.023 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.023 | |
| peptidyl proline hydroxylation to 4 hydroxy l proline | GO:0018401 | 2 | 0.023 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.022 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.022 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.022 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.022 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.022 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.022 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.022 | |
| vesicle organization | GO:0016050 | 60 | 0.022 | |
| regulation of cell migration | GO:0030334 | 219 | 0.021 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.021 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.021 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.021 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.021 | |
| oligosaccharide biosynthetic process | GO:0009312 | 7 | 0.020 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.020 | |
| biomineral tissue development | GO:0031214 | 64 | 0.020 | |
| t cell activation | GO:0042110 | 289 | 0.020 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.020 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.020 | |
| membrane organization | GO:0061024 | 245 | 0.020 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.019 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.019 | |
| bone mineralization | GO:0030282 | 54 | 0.019 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.019 | |
| forebrain development | GO:0030900 | 302 | 0.019 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.019 | |
| regulation of ossification | GO:0030278 | 112 | 0.019 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.019 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.019 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.018 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.018 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.018 | |
| response to inorganic substance | GO:0010035 | 96 | 0.018 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.018 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.018 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.018 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.018 | |
| lipid transport | GO:0006869 | 98 | 0.018 | |
| early endosome to late endosome transport | GO:0045022 | 2 | 0.017 | |
| regulation of sphingolipid biosynthetic process | GO:0090153 | 1 | 0.017 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.017 | |
| protein heterotrimerization | GO:0070208 | 8 | 0.017 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.017 | |
| telencephalon development | GO:0021537 | 186 | 0.017 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.017 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.017 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.017 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.017 | |
| activation of immune response | GO:0002253 | 138 | 0.017 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.017 | |
| negative regulation of type b pancreatic cell apoptotic process | GO:2000675 | 3 | 0.017 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.017 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.016 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.016 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.016 | |
| copii coated vesicle budding | GO:0090114 | 2 | 0.016 | |
| organic anion transport | GO:0015711 | 137 | 0.016 | |
| amine metabolic process | GO:0009308 | 45 | 0.016 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.016 | |
| 4 hydroxyproline metabolic process | GO:0019471 | 5 | 0.016 | |
| extracellular fibril organization | GO:0043206 | 2 | 0.016 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.016 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.016 | |
| transmembrane transport | GO:0055085 | 412 | 0.016 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.016 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.016 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.016 | |
| response to oxygen levels | GO:0070482 | 62 | 0.015 | |
| bone morphogenesis | GO:0060349 | 78 | 0.015 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.015 | |
| protein heterooligomerization | GO:0051291 | 14 | 0.015 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.015 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.015 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.015 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.015 | |
| myotube differentiation | GO:0014902 | 105 | 0.015 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.015 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.015 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.015 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.015 | |
| ceramide biosynthetic process | GO:0046513 | 20 | 0.014 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.014 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.014 | |
| protein localization to organelle | GO:0033365 | 185 | 0.014 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.014 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.014 | |
| golgi vesicle transport | GO:0048193 | 30 | 0.014 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.014 | |
| coagulation | GO:0050817 | 78 | 0.014 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.014 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.014 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.014 | |
| integrin biosynthetic process | GO:0045112 | 1 | 0.014 | |
| protein catabolic process | GO:0030163 | 221 | 0.014 | |
| protein folding | GO:0006457 | 28 | 0.014 | |
| phagocytosis | GO:0006909 | 66 | 0.014 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.014 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.014 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.014 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.014 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.014 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.014 | |
| ear development | GO:0043583 | 200 | 0.014 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.013 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.013 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.013 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.013 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.013 | |
| camera type eye development | GO:0043010 | 266 | 0.013 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.013 | |
| collagen metabolic process | GO:0032963 | 17 | 0.013 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.013 | |
| notochord development | GO:0030903 | 20 | 0.013 | |
| response to calcium ion | GO:0051592 | 20 | 0.013 | |
| stem cell differentiation | GO:0048863 | 268 | 0.013 | |
| sensory perception | GO:0007600 | 245 | 0.013 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.013 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.013 | |
| respiratory system development | GO:0060541 | 190 | 0.013 | |
| chondroblast differentiation | GO:0060591 | 2 | 0.013 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.013 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.013 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.013 | |
| regulation of exit from mitosis | GO:0007096 | 1 | 0.013 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.013 | |
| regulation of system process | GO:0044057 | 200 | 0.013 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.012 | |
| cell recognition | GO:0008037 | 83 | 0.012 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.012 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.012 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.012 | |
| blood coagulation | GO:0007596 | 76 | 0.012 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.012 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.012 | |
| multi organism reproductive behavior | GO:0044705 | 29 | 0.012 | |
| trabecula formation | GO:0060343 | 24 | 0.012 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.012 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.012 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.012 | |
| response to organophosphorus | GO:0046683 | 22 | 0.012 | |
| multicellular organismal catabolic process | GO:0044243 | 7 | 0.012 | |
| cellular water homeostasis | GO:0009992 | 2 | 0.012 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.012 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.012 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.012 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.012 | |
| appendage development | GO:0048736 | 166 | 0.012 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.012 | |
| striated muscle cell development | GO:0055002 | 125 | 0.012 | |
| negative regulation of synapse maturation | GO:2000297 | 2 | 0.012 | |
| dna metabolic process | GO:0006259 | 303 | 0.011 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.011 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.011 | |
| histone modification | GO:0016570 | 159 | 0.011 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.011 | |
| protein secretion | GO:0009306 | 111 | 0.011 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.011 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.011 | |
| heart morphogenesis | GO:0003007 | 178 | 0.011 | |
| antibacterial peptide secretion | GO:0002779 | 1 | 0.011 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.011 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.011 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.011 | |
| regulation of ceramide biosynthetic process | GO:2000303 | 1 | 0.011 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.011 | |
| regulation of action potential | GO:0098900 | 4 | 0.011 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.011 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.011 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.011 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.011 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.011 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.011 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.011 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.011 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.011 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.011 | |
| norepinephrine transport | GO:0015874 | 2 | 0.011 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.011 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.011 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.011 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.011 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.011 | |
| cellular response to lipid | GO:0071396 | 145 | 0.010 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.010 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.010 | |
| response to metal ion | GO:0010038 | 47 | 0.010 | |
| sensory system development | GO:0048880 | 3 | 0.010 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.010 | |
| cell killing | GO:0001906 | 67 | 0.010 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.010 | |
| regulation of secretion | GO:0051046 | 274 | 0.010 | |
| negative regulation of macrophage chemotaxis | GO:0010760 | 1 | 0.010 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.010 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.010 | |
| intussusceptive angiogenesis | GO:0002041 | 2 | 0.010 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.010 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.010 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.010 | |
| sclerotome development | GO:0061056 | 4 | 0.010 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.010 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.010 | |